Outpatient Detox: What to Expect in the First 72 Hours

The Stability Criteria Ohio Programs Use to Say Yes or No

Before any program writes you a benzodiazepine taper or hands you a check-in schedule, someone has to decide you’re a safe candidate for ambulatory care. In Ohio, that decision isn’t a gut call. It’s a regulated gate.

Ohio Administrative Code 4723-9-14 only allows ambulatory withdrawal management with medication when a patient has sufficient social, medical, and psychiatric stability, no severe comorbidities that would make outpatient care unsafe, and a working plan to escalate to emergency or inpatient care if things turn ⁹. Programs must operate under written policies and protocols, with prescriber oversight, rather than improvising case by case ¹⁰. A parallel rule for physicians, 4731-33-02, requires the same protocol-driven approach and ASAM-based placement matching ¹⁷.

In plain language, your intake team is checking four things before they say yes:

1. Are your vitals, labs, and medical history stable enough that withdrawal won’t tip a coexisting condition into crisis?
2. Is your mental health stable enough that you’re not at acute risk of self-harm?
3. Do you have a real human at home?
4. And if your symptoms spike at 2 a.m. on day two, is there a clear path — a phone line, an after-hours clinician, a nearby ER — that gets you help fast ⁹?

If you can answer yes to all four, you’re inside the gate. If you can’t, the right answer isn’t to argue your way in. It’s a higher level of care, which is its own form of progress.

Disqualifiers: When Home Is Not Safe Enough

This part is hard to read if you’ve already decided you want to detox at home. Read it anyway. The disqualifiers exist because the risks are real, not because anyone is trying to talk you out of recovery.

A history of withdrawal seizures or delirium tremens puts you in a different risk category. So does significant medical illness, advanced age, or polysubstance use — particularly heavy use of alcohol combined with benzodiazepines ¹¹. Benzodiazepine dependence itself is a separate problem: withdrawal can cause seizures and psychosis and generally requires a slow, gradual taper under closer supervision than ambulatory programs are built for ⁶. Acute psychiatric instability, including active suicidal thinking, also moves you to inpatient care.

If you fall into one of these categories, you haven’t failed. You’ve gotten useful information. A few days of inpatient stabilization, followed by an outpatient program, is still your recovery — just sequenced differently.

The Sober Support Person Requirement

Ambulatory withdrawal management assumes you are not doing this alone. That’s not a suggestion. It’s part of what “sufficient social support” means in the Ohio rule ⁹.

You need a specific, named adult who is sober, reachable, and physically present in your home for most of the first 72 hours. Their job isn’t to be a nurse. Their job is to notice — to see if you’re more confused than you were two hours ago, to hold and dispense your medication so it isn’t in your hands during a vulnerable moment, to drive you to the clinic or the ER if your team says go, and to call the number on your safety plan when something feels off.

If you live alone and the only candidate is a coworker who can swing by at lunch, that’s not enough. Naming this gap early — before intake — gives your team time to help you solve it, whether that means a family member staying over or a short inpatient stay instead.

What Happens at the First Visit

Your first appointment usually lasts longer than you expect — plan on two to three hours. You’re not just signing forms. The clinician is building a baseline they’ll measure everything else against for the next three days.

Expect a focused medical history: how much you’ve been drinking or using, when your last dose was, prior withdrawal episodes, any history of seizures or delirium tremens, other medications, and coexisting medical or psychiatric conditions ¹¹. Vital signs come next — blood pressure, heart rate, temperature — followed in most programs by basic labs to check liver function, electrolytes, and hydration. A nurse or pharmacist will inventory what’s in your medicine cabinet at home and confirm who your sober support person is and where they’ll be sleeping for the next three nights ⁹.

Then comes the first CIWA-Ar assessment, your medication plan, and a written safety plan: the after-hours number, the nearest ER, and the specific symptoms that mean you call before your next scheduled check-in. You’ll leave with a small, dated supply of medication — not a full bottle — and a check-in window for the next morning. That last detail is deliberate. Day two is coming, and your team wants eyes on you before it arrives.

CIWA-Ar and How Your Score Drives Care

CIWA-Ar stands for the Clinical Institute Withdrawal Assessment for Alcohol, Revised. It’s a 10-item checklist a clinician walks through with you in about five minutes: nausea, tremor, sweating, anxiety, agitation, headache, sensitivity to light and sound, tactile and visual disturbances, and orientation ¹. Each item is scored, the numbers are added up, and the total tells your team how much medication you actually need right now — not how much a textbook says someone your size should need.

The score bands are simple:

• A total under 8 to 10 indicates minimal to mild withdrawal.
• A score of 8 to 15 indicates moderate withdrawal.
• A score of 15 or higher indicates severe withdrawal ¹.

In ambulatory care, those bands map to three different responses: supportive care and hydration at the low end, symptom-triggered benzodiazepine dosing in the middle band, and transfer to a higher level of care at the top ¹³.

You’ll likely be scored several times in the first 24 hours — at intake, by phone or video check-in that evening, and again the next morning. The point isn’t to assign you a grade. It’s to catch a rising trend early, while the medication you take at home can still keep you ahead of it. If your score is climbing visit over visit despite dosing, your team isn’t going to push through. They’re going to move you. That’s the system working, not failing.

Why Day Two Is the Hardest Day

You’ll wake up on day two and something will be different. Not necessarily worse than the worst moment of day one, but more relentless. The tremor that came and went yesterday is steadier. Sleep, if you got any, was thin. Your skin feels wrong.

This isn’t bad luck or weakness. It’s pharmacology. Alcohol withdrawal signs begin within 6 to 24 hours after your last drink, peak in intensity between 24 and 48 hours, and generally resolve within 4 to 5 days, with medication tapers like chlordiazepoxide structured across days 1 through 3 to cover exactly this curve ⁵. Your team built your schedule around that shape. The morning check-in on day two isn’t a routine appointment. It’s the visit they care about most.

Expect more frequent CIWA-Ar scoring during this window, sometimes every few hours by phone or video, plus a same-day in-person visit if anything is trending up ¹³. Your support person will likely be asked direct questions about your sleep, your confusion, and whether you’ve kept fluids down.

Knowing day two is the peak is itself useful information. You’re not getting worse forever. You’re climbing the part of the curve that already has a top.

Medications: Benzodiazepines, Gabapentin, and What Your Team Is Choosing Between

For alcohol withdrawal in the ambulatory setting, the workhorse is still a benzodiazepine — most often chlordiazepoxide, sometimes diazepam or lorazepam — given either on a fixed taper over days 1 through 3 or, more commonly now, on a symptom-triggered schedule driven by your CIWA-Ar scores ^{5, 13}. Symptom-triggered dosing means you take medication when your score crosses a threshold, not on a fixed clock. Studies in emergency and outpatient settings support this approach as effective when monitoring is reliable ².

Gabapentin has entered the conversation as a non-benzodiazepine alternative. A randomized trial directly compared gabapentin with chlordiazepoxide in ambulatory alcohol withdrawal, testing whether gabapentin is non-inferior for managing symptoms with close outpatient monitoring ⁴. For some patients — particularly those with a history of benzodiazepine misuse, sedation concerns, or work obligations that make heavy benzodiazepine dosing impractical — gabapentin may be part of the plan, sometimes alongside lower-dose benzodiazepines rather than instead of them.

You may also see supportive medications: thiamine and folate to protect against nutritional deficits, ondansetron for nausea, clonidine for autonomic symptoms, and adequate hydration. None of these replace the core taper. They make the core taper tolerable.

One honest note about handling. Your medication will usually be dispensed in small, dated quantities rather than a full prescription. That’s not distrust. It’s protocol — and in Ohio, it reflects the written-policy requirements both nursing and physician rules impose on ambulatory programs ^{16, 17}.

Red Flags: When to Call, When to Go to the ER

Most of day two is uncomfortable but manageable. A specific subset of symptoms is not, and you need to know them cold before they happen.

Call your team between scheduled check-ins if any of these appear:

• A CIWA-Ar score that keeps climbing despite your last dose
• Vomiting that prevents you from keeping medication down
• A heart rate that stays above 120
• Persistent fever
• New visual or tactile hallucinations ^{1, 13}

These don’t automatically mean the ER. They mean your clinician needs to hear about them now, not at the next appointment.

If you’re unsure, call. The escalation plan your team built at intake exists for this moment, and using it isn’t a setback. It’s the system working.

What Improvement Actually Looks Like

By the third morning, the curve starts bending the other way. Your tremor is quieter. Your appetite flickers back. You slept more than two hours in a row. None of this means you’re done — alcohol withdrawal generally resolves within 4 to 5 days, not 3 ⁵— but day three is usually when the trend line turns.

Your CIWA-Ar scores should be drifting down visit over visit. If yesterday’s morning score was 11 and today’s is 6, that’s the number your team wants to see ¹. Medication doses come down with the scores. The check-in cadence loosens a little — maybe one in-person visit and a video call instead of two visits. You may feel emotionally raw or unexpectedly tearful. That’s normal and worth telling someone about.

Small wins count here. You kept the morning dose down. You drank water. You answered the phone.

Why Detox Without Follow-On Treatment Fails

Here’s the part most people don’t hear at intake: finishing 72 hours of detox is not finishing treatment. It’s finishing the first three days.

National guidance is direct about this. Withdrawal management without ongoing pharmacotherapy is not an adequate standalone treatment for opioid use disorder, and medications for opioid use disorder should generally be used for maintenance rather than brief detox alone, because withdrawal without ongoing care is associated with high relapse and overdose risk ^{8, 14}. The same logic applies to alcohol. SAMHSA names acamprosate, disulfiram, and naltrexone as the most common medications used for alcohol use disorder, and emphasizes pairing medication with counseling and behavioral therapies ⁷. Ambulatory detox literature flags the same concern — relapse and overdose risk climb after short-term detox if it isn’t followed by ongoing addiction treatment ¹².

So before you hit hour 72, your team should already have the next thing scheduled. An intensive outpatient or standard outpatient program. A first counseling appointment. A MAT prescriber visit if that’s part of your plan. A name and a calendar slot, not a brochure.

If your discharge conversation sounds like “you’re done, good luck,” push back. The handoff is the treatment.

Symptom Profile and Timeline for Short-Acting Opioids

If you’re coming off a short-acting opioid like heroin, oxycodone, or hydrocodone, your first 72 hours will not look like alcohol withdrawal. The timeline is different, the danger profile is different, and the medications your team reaches for are different.

Symptoms usually start 8 to 24 hours after your last dose and climb fast: muscle aches, abdominal cramping, nausea and vomiting, diarrhea, runny nose, watery eyes, yawning, goosebumps, restlessness, and a deep, joint-level discomfort that makes sitting still feel impossible. Anxiety and insomnia run underneath all of it. For short-acting opioids, the peak typically lands somewhere in the 36–72 hour window before the worst of it begins to ease over the following days.

Here is the most important difference. Opioid withdrawal is severely uncomfortable but is usually not life-threatening on its own, and it can be managed in ambulatory settings with opioid agonists or symptomatic medications when monitoring and follow-up are in place ⁶. That doesn’t mean white-knuckling it at home. It means the danger in opioid withdrawal isn’t usually the withdrawal itself — it’s what people do to make it stop.

Buprenorphine, Methadone, and Clonidine in the First 72 Hours

Ambulatory opioid withdrawal can be safely conducted using methadone, buprenorphine/naloxone, clonidine, guanfacine, and supportive care when appropriate monitoring and follow-up are provided ¹². Those aren’t competing options. They’re a layered toolkit your prescriber chooses from based on what you used, when you last used, and what comes next.

Buprenorphine is the most common starting point in outpatient care. It’s a partial opioid agonist that quiets withdrawal and cravings within an hour or two of the first dose, and your induction visit will be carefully timed: you need to already be in mild-to-moderate withdrawal before the first dose, or it can precipitate worse symptoms. Methadone is the alternative for patients who need a full agonist or who haven’t tolerated buprenorphine, though it’s dispensed through licensed opioid treatment programs rather than a general outpatient clinic. Clonidine, an alpha-2 agonist, takes the edge off the autonomic symptoms — the sweating, the racing heart, the runny nose — and is often used alongside other supportive medications like ondansetron for nausea and loperamide for diarrhea ^{6, 12}.

One non-negotiable point: SAMHSA and ASAM are direct that medications for opioid use disorder should generally be used for maintenance, not brief detox alone, because withdrawal without ongoing treatment carries high relapse and overdose risk ^{8, 14}. If buprenorphine is started in your first 72 hours, the plan should already extend past day three — into ongoing prescribing, counseling, and an outpatient program. Detox without that bridge isn’t a finished treatment. It’s an unfinished one.